Skip to main content
Erschienen in: Wiener klinische Wochenschrift 13-14/2015

01.07.2015 | original article

Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?

verfasst von: Asist. Prof. Dr. Tolga Kurt, Asist. Prof. Dr. Ahmet Temiz, Asist. Prof. Dr. Ferhat Gokmen, Asist. Prof. Dr. Gurhan Adam, Asist. Prof. Dr. Sedat Ozcan, Asist. Prof. Dr. Ersan Ozbudak, Prof. Dr. Mustafa Sacar

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2015

Einloggen, um Zugang zu erhalten

Summary

Background

It takes years for atherosclerosis to manifest symptoms. However, it needs to be identified earlier because of the premature cardiovascular risk factors in patients with rheumatoid arthritis (RA). In this study, we aimed to investigate the effect of atherosclerosis on the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) in patients with RA.

Methods

RA patients attending the rheumatology clinic were examined retrospectively; then we called them for the measurements of ABPI and CIMT prospectively. Subjects were divided into four groups, as follows (Table 1): group 1 comprised RA patients with an ABPI less than 0.9; group 2 included RA patients with an ABPI between 0.9 and 1.2; group 3 was made up of RA patients with an ABPI greater than 1.2; and group 4 included patients without RA with an ABPI between 0.9 and 1.2 as a control group. Patients’ demographic data were recorded. Hypertension (HT), diabetes mellitus, ABPI and CIMT measurements were taken by specialists. Duration of RA and disease scores (disease activity score-28, health assessment questionnaire score and visual assessment score) were recorded.

Results

The prevalence of peripheral vascular disease in patients with RA was twice as high as that in the normal population of equivalent age. Patients in group 2, with RA and normal ABPI, exhibited a significant higher mean in CIMT (mm) compared with the control group (p < 0.01), despite having normal ABPI. This confirms that these patients have a higher risk of stroke compared with the control group. Group 1’s newly diagnosed HT (p < 0.01) and systolic blood pressure (SBP) values (p < 0.01) were higher and statistically significant when compared with the group 4 (control group); in addition, significant plaque levels were observed in the carotid arteries (p < 0.01). Group 3 patients had a similar history of HT and increased SBP compared with patients in group 4 (p < 0.01), and had similar characteristics to with group 1. No statistically significant differences were found between the groups in terms of inflammatory markers such as C-reactive protein and rheumatoid factor, anti-cyclic citrullinated peptide and white blood cell counts.

Conclusion

Based on the present findings, patients with RA need to be evaluated in the early stage of the disease for subclinical peripheral artery disease using the ABPI, as well as CIMT, which is also a non-invasive technique, in terms of cerebrovascular events. Inflammatory markers exhibited no statistically significant difference. We think that the atherosclerotic process stems not only from the inflammatory effects of RA, but also perhaps from its immunological nature.
Literatur
1.
Zurück zum Zitat Pieringer H, Pichler M, Pohanka E, Hoppe UC. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis? Curr Pharm Des. 2014;20(4):486–95.PubMedCrossRef Pieringer H, Pichler M, Pohanka E, Hoppe UC. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis? Curr Pharm Des. 2014;20(4):486–95.PubMedCrossRef
2.
Zurück zum Zitat Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.PubMedCrossRef Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.PubMedCrossRef
3.
Zurück zum Zitat Bacon PA, Stevens RJ, Carruthers DM, Young SP, et al. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev. 2002;1(6):338–47.PubMedCrossRef Bacon PA, Stevens RJ, Carruthers DM, Young SP, et al. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev. 2002;1(6):338–47.PubMedCrossRef
4.
Zurück zum Zitat Evans MR, Escalante A, Battafarano DF, et al. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum. 2011;63(5):1211–20.PubMedCentralPubMedCrossRef Evans MR, Escalante A, Battafarano DF, et al. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum. 2011;63(5):1211–20.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008;58(2):359–69.PubMedCentralPubMedCrossRef Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008;58(2):359–69.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Sohaib A, Swati G, Minakshi D. Predictors of atherosclerosis in rheumatoid arthritis. Vasa. 2012;41:353–59.CrossRef Sohaib A, Swati G, Minakshi D. Predictors of atherosclerosis in rheumatoid arthritis. Vasa. 2012;41:353–59.CrossRef
7.
Zurück zum Zitat Mookadam F, Moustafa SE, Lester SJ, et al. Subclinical atherosclerosis: evolving role of carotid intima media thickness. Prev Cardiol. 2010;13:186–97.PubMedCrossRef Mookadam F, Moustafa SE, Lester SJ, et al. Subclinical atherosclerosis: evolving role of carotid intima media thickness. Prev Cardiol. 2010;13:186–97.PubMedCrossRef
8.
Zurück zum Zitat Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50–103. doi:10.1016/j.jacc.2010.09.001.PubMedCrossRef Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50–103. doi:10.1016/j.jacc.2010.09.001.PubMedCrossRef
9.
Zurück zum Zitat Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111; quiz 189–90. doi:10.1016/j.echo.2007.11.011.PubMedCrossRef Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111; quiz 189–90. doi:10.1016/j.echo.2007.11.011.PubMedCrossRef
10.
Zurück zum Zitat Heald CL, Fowkes FG, Murray GD, et al. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.PubMedCrossRef Heald CL, Fowkes FG, Murray GD, et al. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.PubMedCrossRef
11.
Zurück zum Zitat Del Rincón I, O’Leary DH, Haas RW, et al. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum. 2004;50:3813–22.PubMedCrossRef Del Rincón I, O’Leary DH, Haas RW, et al. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum. 2004;50:3813–22.PubMedCrossRef
12.
Zurück zum Zitat Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012;8(4):224–34. doi:10.1038/nrrheum.2012.16.PubMedCrossRef Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012;8(4):224–34. doi:10.1038/nrrheum.2012.16.PubMedCrossRef
13.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRef
14.
Zurück zum Zitat Bartels CM, Johnson H, Voelker K et al. Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res (Hoboken). 2014. doi:10.1002/acr.22302. Bartels CM, Johnson H, Voelker K et al. Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res (Hoboken). 2014. doi:10.1002/acr.22302.
15.
Zurück zum Zitat Garza-García C, Rocío SS, Orea-Tejeda A, et al. Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. Cardiol. 2013;2013:635439. doi:10.1155/2013/635439 (eCollection 2013). Garza-García C, Rocío SS, Orea-Tejeda A, et al. Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. Cardiol. 2013;2013:635439. doi:10.1155/2013/635439 (eCollection 2013).
16.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005;35:8–17.PubMedCrossRef Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005;35:8–17.PubMedCrossRef
17.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003;82(6):407–13.CrossRef Gonzalez-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003;82(6):407–13.CrossRef
18.
Zurück zum Zitat Criqui MH, Fronek A, Connor EB, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–15.PubMedCrossRef Criqui MH, Fronek A, Connor EB, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–15.PubMedCrossRef
19.
Zurück zum Zitat Van Sijl AM, Peters MJ, Knol DK, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011;40(5):389–97.PubMedCrossRef Van Sijl AM, Peters MJ, Knol DK, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011;40(5):389–97.PubMedCrossRef
20.
Zurück zum Zitat Society of Atherosclerosis Imaging and Prevention Developed in collaboration with the International Atherosclerosis Society. Appropriate use criteria for carotid intima media thickness testing. Atherosclerosis. 2011;214(1):43–6.CrossRef Society of Atherosclerosis Imaging and Prevention Developed in collaboration with the International Atherosclerosis Society. Appropriate use criteria for carotid intima media thickness testing. Atherosclerosis. 2011;214(1):43–6.CrossRef
21.
Zurück zum Zitat Mohan A, Sada S, Kumar BS, et al. Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. Indian J Med Res. 2014;140(3):379–86.PubMedCentralPubMed Mohan A, Sada S, Kumar BS, et al. Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. Indian J Med Res. 2014;140(3):379–86.PubMedCentralPubMed
22.
Zurück zum Zitat López-Mejías R, Genre F, García-Bermúdez M, et al. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R152.PubMedCentralPubMedCrossRef López-Mejías R, Genre F, García-Bermúdez M, et al. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R152.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat López-Mejías R, Genre F, Corrales A. Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:1749–50. doi:10.1136/annrheumdis-2014-205543.PubMedCrossRef López-Mejías R, Genre F, Corrales A. Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:1749–50. doi:10.1136/annrheumdis-2014-205543.PubMedCrossRef
24.
Zurück zum Zitat Del Rincon I, Haas RW, Pogosian S, et al. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis. 2005;64:425–32.PubMedCentralPubMedCrossRef Del Rincon I, Haas RW, Pogosian S, et al. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis. 2005;64:425–32.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Guellec D, Bressollette L, Gueguen F, et al. Is routine ankle-brachial pressure index evaluation useful in rheumatoid arthritis? Joint Bone Spine. 2013;80(1):111–3PubMedCrossRef Guellec D, Bressollette L, Gueguen F, et al. Is routine ankle-brachial pressure index evaluation useful in rheumatoid arthritis? Joint Bone Spine. 2013;80(1):111–3PubMedCrossRef
26.
Zurück zum Zitat Ristic´ GG, Lepic´ T, Glisic´ B, et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford). 2010;49(6):1076–81.CrossRef Ristic´ GG, Lepic´ T, Glisic´ B, et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford). 2010;49(6):1076–81.CrossRef
27.
Zurück zum Zitat Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1489–97.PubMedCrossRef Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1489–97.PubMedCrossRef
28.
Zurück zum Zitat Daza L, Aguirre M, Jimenez M, et al. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol. 2007;26(4):533–7.PubMedCrossRef Daza L, Aguirre M, Jimenez M, et al. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol. 2007;26(4):533–7.PubMedCrossRef
29.
Zurück zum Zitat Corrales A, Parra JA, Juanatey CG, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2013;72:1764–70. doi:10.1136/annrheumdis-2013-203688.PubMedCrossRef Corrales A, Parra JA, Juanatey CG, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2013;72:1764–70. doi:10.1136/annrheumdis-2013-203688.PubMedCrossRef
Metadaten
Titel
Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?
verfasst von
Asist. Prof. Dr. Tolga Kurt
Asist. Prof. Dr. Ahmet Temiz
Asist. Prof. Dr. Ferhat Gokmen
Asist. Prof. Dr. Gurhan Adam
Asist. Prof. Dr. Sedat Ozcan
Asist. Prof. Dr. Ersan Ozbudak
Prof. Dr. Mustafa Sacar
Publikationsdatum
01.07.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0767-x

Weitere Artikel der Ausgabe 13-14/2015

Wiener klinische Wochenschrift 13-14/2015 Zur Ausgabe

mitteilungen der gesellschaft

ÖGIM FLIP